Literature DB >> 21078976

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2).

Nicola Valeri1, Pierluigi Gasparini, Chiara Braconi, Alessio Paone, Francesca Lovat, Muller Fabbri, Khlea M Sumani, Hansjuerg Alder, Dino Amadori, Tushar Patel, Gerard J Nuovo, Richard Fishel, Carlo M Croce.   

Abstract

The overexpression of microRNA-21 (miR-21) is linked to a number of human tumors including colorectal cancer, where it appears to regulate the expression of tumor suppressor genes including p21, phosphatase and tensin homolog, TGFβ receptor II, and B-cell leukemia/lymphoma 2 -associated X protein. Here we demonstrate that miR-21 targets and down-regulates the core mismatch repair (MMR) recognition protein complex, human mutS homolog 2 (hMSH2) and 6 (hMSH6). Colorectal tumors that express a high level of miR-21 display reduced hMSH2 protein expression. Cells that overproduce miR-21 exhibit significantly reduced 5-fluorouracil (5-FU)-induced G2/M damage arrest and apoptosis that is characteristic of defects in the core MMR component. Moreover, xenograft studies demonstrate that miR-21 overexpression dramatically reduces the therapeutic efficacy of 5-FU. These studies suggest that the down-regulation of the MMR mutator gene associated with miR-21 overexpression may be an important clinical indicator of therapeutic efficacy in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078976      PMCID: PMC3000294          DOI: 10.1073/pnas.1015541107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.

Authors:  R Fishel
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

2.  Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer.

Authors:  Y Watanabe; A Haugen-Strano; A Umar; K Yamada; H Hemmi; Y Kikuchi; S Takano; Y Shibata; J C Barrett; T A Kunkel; M Koi
Journal:  Mol Carcinog       Date:  2000-09       Impact factor: 4.784

3.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

Authors:  Michael J O'Connell; Ian Lavery; Greg Yothers; Soonmyung Paik; Kim M Clark-Langone; Margarita Lopatin; Drew Watson; Frederick L Baehner; Steven Shak; Joffre Baker; J Wayne Cowens; Norman Wolmark
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

4.  Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.

Authors:  G Samimi; D Fink; N M Varki; A Husain; W J Hoskins; D S Alberts; S B Howell
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

5.  Modulation of mismatch repair and genomic stability by miR-155.

Authors:  Nicola Valeri; Pierluigi Gasparini; Muller Fabbri; Chiara Braconi; Angelo Veronese; Francesca Lovat; Brett Adair; Ivan Vannini; Francesca Fanini; Arianna Bottoni; Stefan Costinean; Sukhinder K Sandhu; Gerard J Nuovo; Hansjuerg Alder; Roberta Gafa; Federica Calore; Manuela Ferracin; Giovanni Lanza; Stefano Volinia; Massimo Negrini; Michael A McIlhatton; Dino Amadori; Richard Fishel; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  Fecal MicroRNAs as novel biomarkers for colon cancer screening.

Authors:  Alexander Link; Francesc Balaguer; Yan Shen; Takeshi Nagasaka; Juan José Lozano; C Richard Boland; Ajay Goel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-15       Impact factor: 4.254

8.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

Authors:  Pedro P Medina; Mona Nolde; Frank J Slack
Journal:  Nature       Date:  2010-08-08       Impact factor: 49.962

9.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

Review 10.  5-fluorouracil: mechanisms of action and clinical strategies.

Authors:  Daniel B Longley; D Paul Harkin; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

View more
  171 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  Modulation of microRNA processing by mismatch repair protein MutLα.

Authors:  Guogen Mao; Sanghee Lee; Janice Ortega; Liya Gu; Guo-Min Li
Journal:  Cell Res       Date:  2012-01-31       Impact factor: 25.617

3.  Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications.

Authors:  Frank A Sinicrope; Daniel J Sargent
Journal:  Clin Cancer Res       Date:  2012-02-02       Impact factor: 12.531

Review 4.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

5.  Investigation of microRNA expression and DNA repair gene transcripts in human oocytes and blastocysts.

Authors:  P Tulay; R P Naja; O Cascales-Roman; A Doshi; P Serhal; S B SenGupta
Journal:  J Assist Reprod Genet       Date:  2015-10-05       Impact factor: 3.412

Review 6.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

7.  MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.

Authors:  Guopei Zheng; Nan Li; Xiaoting Jia; Cong Peng; Liyun Luo; Yingen Deng; Jiang Yin; Ying Song; Hao Liu; Minying Lu; Zhijie Zhang; Yixue Gu; Zhimin He
Journal:  J Mol Med (Berl)       Date:  2016-04-08       Impact factor: 4.599

8.  An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Nicola Valeri; John Stevens; Bette J Caan; Wade Samowitz; Roger K Wolff
Journal:  Int J Cancer       Date:  2014-12-16       Impact factor: 7.396

9.  Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy.

Authors:  E M Saleh; R A El-Awady; N Anis
Journal:  Oncol Lett       Date:  2012-10-11       Impact factor: 2.967

10.  miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene.

Authors:  Lisa W Witten; Christopher J Cheng; Frank J Slack
Journal:  Oncogene       Date:  2018-11-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.